A comprehensive review of cancer: CRISPR and its application in lung cancer with a potential in overcoming EGFR mutations

Saamya Yadav; Poonam Agrawal

doi:10.30574/ijsra.2024.13.1.2016

ISSN Approved Journal || eISSN: 2582-8185 || CODEN: IJSRO2 || Impact Factor 8.2 || Google Scholar and CrossRef Indexed

Peer Reviewed and Referred Journal || Free Certificate of Publication

Research and review articles are invited for publication in March 2026 (Volume 18, Issue 3) Submit manuscript

A comprehensive review of cancer: CRISPR and its application in lung cancer with a potential in overcoming EGFR mutations

Saamya Yadav ^{1, *} and Poonam Agrawal ²

1 Santa Clara High School, United States of America.
2 Beckman Center for Molecular and Genetic Medicine, School of Medicine, Stanford University, United States of America.

Review Article

International Journal of Science and Research Archive, 2024, 13(01), 3047–3067.
Article DOI: 10.30574/ijsra.2024.13.1.2016
DOI url: https://doi.org/10.30574/ijsra.2024.13.1.2016

Publication history

Received on 13 September 2024; revised on 20 October 2024; accepted on 23 October 2024

Abstract

As a comprehensive review of cancer, oncogenes, and CRISPR, this review explores the transformative potential of CRISPR technology in combating cancer, particularly focusing on lung cancer and oncogenes. CRISPR’s precision gene-editing capabilities offer a promising avenue for developing more targeted cancer therapies, overcoming the limitations of current treatments such as chemotherapy and radiation, which often fail due to cancer cell heterogeneity and resistance. Additionally, this review proposes the potential use of CRISPR to target specific oncogenes like EGFR and its significant promise for improving treatment outcomes in lung cancer by directly modifying or regulating gene function. This review synthesizes current research, highlighting the integration of CRISPR with other therapeutic modalities to enhance the effectiveness of cancer treatments, delivery systems that improve targeting and minimize off-target effects, and the future directions in CRISPR-mediated lung cancer therapy.

Keywords

CRISPR; Cancer; Lung Cancer; Targeted Therapy; EGFR

Download Article PDF

https://ijsra.net/sites/default/files/fulltext_pdf/IJSRA-2024-2016.pdf

Preview Article PDF

How to cite this article

Saamya Yadav and Poonam Agrawal. A comprehensive review of cancer: CRISPR and its application in lung cancer with a potential in overcoming EGFR mutations. International Journal of Science and Research Archive, 2024, 13(01), 3047–3067. https://doi.org/10.30574/ijsra.2024.13.1.2016

Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.

All statements, opinions, and data contained in this publication are solely those of the individual author(s) and contributor(s). The journal, editors, reviewers, and publisher disclaim any responsibility or liability for the content, including accuracy, completeness, or any consequences arising from its use.